Cargando…

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease

The relationship between body-mass index (BMI) and Alzheimer´s disease (AD) has been extensively investigated. However, BMI alterations in preclinical individuals with autosomal dominant AD (ADAD) have not yet been investigated. We analyzed cross-sectional data from 230 asymptomatic members of famil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Stephan, Preische, Oliver, Sohrabi, Hamid R., Gräber, Susanne, Jucker, Mathias, Dietzsch, Janko, Ringman, John M., Martins, Ralph N., McDade, Eric, Schofield, Peter R., Ghetti, Bernardino, Rossor, Martin, Graff-Radford, Neill R., Levin, Johannes, Galasko, Douglas, Quaid, Kimberly A., Salloway, Stephen, Xiong, Chengjie, Benzinger, Tammie, Buckles, Virginia, Masters, Colin L., Sperling, Reisa, Bateman, Randall J., Morris, John C., Laske, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430642/ https://www.ncbi.nlm.nih.gov/pubmed/28450713 http://dx.doi.org/10.1038/s41598-017-01327-w

Ejemplares similares

Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis
por: Tang, Mengxuan, et al.
Publicado: (2016)

The pattern of atrophy in familial Alzheimer disease: Volumetric MRI results from the DIAN study
por: Cash, David M., et al.
Publicado: (2013)

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
por: Lee, Seonjoo, et al.
Publicado: (2018)

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
por: Bateman, Randall J, et al.
Publicado: (2011)

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
por: Ringman, John M., et al.
Publicado: (2014)

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Increased Diagnostic Accuracy of Digital vs. Conventional Clock Drawing Test for Discrimination of Patients in the Early Course of Alzheimer’s Disease from Cognitively Healthy Individuals
por: Müller, Stephan, et al.
Publicado: (2017)

Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study
por: Laske, Christoph, et al.
Publicado: (2015)

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2021)

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
por: Araque Caballero, Miguel Ángel, et al.
Publicado: (2018)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials
por: Aschenbrenner, Andrew J., et al.
Publicado: (2022)

A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease
por: Grill, Joshua D., et al.
Publicado: (2015)

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
por: Su, Yi, et al.
Publicado: (2019)

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study
por: Gordon, Brian A., et al.
Publicado: (2018)

Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer’s disease from healthy individuals
por: Müller, Stephan, et al.
Publicado: (2019)

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2022)

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2023)

Legionella and the Prevention of Legionellosis
por: McDade, Joseph E.
Publicado: (2008)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Addressing the potential threat of bioterrorism--value added to an improved public health infrastructure.
por: McDade, J E
Publicado: (1999)

The Microbial Challenge: Human-Microbe Interactions
por: McDade, Joseph E.
Publicado: (2002)

Pro: Can biomarkers be gold standards in Alzheimer's disease?
por: Sperling, Reisa, et al.
Publicado: (2010)

Signature of Alzheimer’s Disease in Intestinal Microbiome: Results From the AlzBiom Study
por: Laske, Christoph, et al.
Publicado: (2022)

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2021)

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
por: Gonneaud, Julie, et al.
Publicado: (2021)

Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
por: Groveman, Bradley R., et al.
Publicado: (2018)

Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
por: Groveman, Bradley R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ausqgv7p1ktc5a90es2dkjdko